Company: INMB
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001213900-25-041072
Chunk: 95

Company: Inmune Bio, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 1
Chunk 95
---

      inmb:INKmuneLicenseAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      inmb:MilestonePaymentPhaseThreeInitiationMember
      inmb:INKmuneLicenseAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      inmb:MilestonePaymentNdaEmaFilingMember
      inmb:INKmuneLicenseAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      inmb:MilestonePaymentNdaEmaAwardedMember
      inmb:INKmuneLicenseAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      inmb:EachPhaseInitiationMember
      inmb:PITTAgreementMember

    2025-01-01
    2025-03-31

    0001711754

      inmb:EachPhaseIIIInitiationMember
      inmb:PITTAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      us-gaap:TechnologyBasedIntangibleAssetsMember
      inmb:PITTAgreementMember

    2025-01-01
    2025-03-31

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueMeasurementsRecurringMember

    2025-03-31

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueInputsLevel1Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-03-31

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueInputsLevel2Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-03-31

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueInputsLevel3Member
      us